Whalesbook
Geopolitics ka funda aur market pe impact
March 2026 mein Indian stock market mein jabardast sell-off dekha gaya hai. Asal mein, Middle East mein Iran, Israel aur US ke beech jo conflict badh raha hai, usne sabka dhyan kheench liya hai. Is wajah se dar hai ki kahin lamba regional war na chid jaaye, jisne oil supply routes ko bhi khatre mein daal diya hai. Brent crude oil ka rate $100 per barrel ke paar chala gaya, aur late March mein toh $116.70 tak bhi pahunch gaya tha intraday mein.
Ek taraf toh yeh geopolitical tension aur doosri taraf badhti energy prices, isi beech mein foreign institutional investors (FIIs) ne March mein hi lagbhag ₹1.14 lakh crore ke shares bech diye. Yeh ek mahine mein FIIs ka sabse bada outflow hai! Isi risk averse sentiment ke chalte, market mein girawat aayi. March 30 ko toh Sensex bhi 1% se zyada gir gaya, aur Nifty 50 toh 22,500 ke neeche chala gaya. Bank Nifty ka toh aur bura haal raha, around 2.16% gir gaya ek hafte mein. BSE MidCap aur SmallCap indices bhi around 1.4% gir gaye March 30 ko. India VIX, jo market volatility batata hai, woh bhi kaafi badh gaya, matlab investors mein dar ka mahaul hai.
Pharma aur Power Sector ka kya hua?
Aise girte hue market mein bhi kuch sectors thoda sambhalte dikh rahe the, jaise ki Pharma aur Power. Lekin dhyan se dekha jaaye toh woh bhi poori tarah is negativity se bach nahi paaye. Nifty Pharma index toh March 20 tak 1.28% gir gaya tha aur March 30 ko toh 2% tak fisalta dikha. Nifty IT aur Pharma indices toh March 28 ko khatam hone wale hafte mein thoda sa positive rahe (1.17% aur 0.11%), par yeh bahut kam tha.
Power sector mein bhi mix performance raha. Kuch PSU stocks ne resilience dikhai, par kuch bade stocks ko bhi dikkat hui. Power Grid Corporation ke liye toh analyst ne March ke start mein 'Sell' rating di thi, baad mein 'Hold' kar diya, jo sector ki challenges dikhata hai. S&P BSE Energy sector toh March 30 ko sirf 0.01% hi badha.
Valuations aur Investor ki positioning
Market girne ke baad valuations kaafi interesting dikh rahe hain. Bank Nifty ka Price-to-Earnings (P/E) ratio 14.00 par tha. Nifty Smallcap 100 ka P/E 27.83 tha, jo 7-year median se 7% neeche hai. Nifty Midcap 100 ka P/E 30.10 tha, jo median se upar tha, par Nifty Midcap Select ka P/E 26.55 tha, jo median se 23.34% neeche hai. Yeh numbers attractive lag sakte hain, par dar ki wajah se log abhi invest karne se dar rahe hain.
Aage kya risk hai?
Pharma sector mein input costs aur supply chain issues badh sakte hain. Power sector mein execution aur policy dependence ek risk hai. Macroeconomic outlook bhi thoda clouded hai, energy prices aur manufacturing activity ka combination dikh raha hai. US Dollar ka strong rehna aur US bond yields ka badhna bhi foreign investors ke liye developed markets ko zyada attractive bana raha hai.
Aage ka outlook
Analysts filhaal bahut cautious hain aur keh rahe hain ki funda-mentally strong stocks pe hi dhyaan dena chahiye. Market abhi volatile rehne wala hai aur Middle East ki situation pe depend karega. Agar tensions kam hui toh April mein recovery ho sakti hai, par abhi uncertainty hai. FY27 mein GDP growth 6.5% rehne ka estimate hai jo FY26 ke 7.5% se kam hai. Jab tak global risk sentiment theek nahi hota, tab tak range-bound movement aur volatility expected hai.